High <i>PAPPA</i> expression was associated with poorer overall survival in bladder, cervical, lung squamous, mesothelioma, pancreatic, and gastric cancers, but exhibited a protective effect in lower-grade glioma. This evidence concerns the gene PAPPA and central nervous system cancer.